[{"address1": "18105 SE Mill Plain Boulevard", "city": "Vancouver", "state": "WA", "zip": "98683", "country": "United States", "phone": "360 949 1041", "website": "https://www.absci.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean  McClain", "age": 34, "title": "Founder, CEO, President & Director", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 1005200, "exercisedValue": 0, "unexercisedValue": 1193075}, {"maxAge": 1, "name": "Dr. Zachariah  Jonasson Ph.D.", "age": 50, "title": "Chief Business Officer & CFO", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 331637, "exercisedValue": 0, "unexercisedValue": 217413}, {"maxAge": 1, "name": "Dr. Andreas  Busch Ph.D.", "age": 61, "title": "Chief Innovation Officer & Member of Scientific Advisory Board", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1132884, "exercisedValue": 0, "unexercisedValue": 768752}, {"maxAge": 1, "name": "Mr. Todd  Bedrick CPA", "title": "Senior VP & Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelby  Walker J.D.", "age": 49, "title": "Chief Legal Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karin  Wierinck", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Melissa  Patterson Ph.D.", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jens  Plassmeier Ph.D.", "title": "Senior Vice President of Synthetic Biology R&D", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wen  Sha", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christine  Lemke D.V.M., M.B.A., Ph.D.", "title": "Senior Vice President of Portfolio & Growth Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.0, "open": 5.09, "dayLow": 5.03, "dayHigh": 5.85, "regularMarketPreviousClose": 5.0, "regularMarketOpen": 5.09, "regularMarketDayLow": 5.03, "regularMarketDayHigh": 5.85, "beta": 2.125, "forwardPE": -7.7086096, "volume": 9701329, "regularMarketVolume": 9701329, "averageVolume": 4565854, "averageVolume10days": 5616910, "averageDailyVolume10Day": 5616910, "bid": 4.19, "ask": 6.52, "bidSize": 200, "askSize": 200, "marketCap": 668461952, "fiftyTwoWeekLow": 2.45, "fiftyTwoWeekHigh": 6.72, "priceToSalesTrailing12Months": 158.89279, "fiftyDayAverage": 3.5128, "twoHundredDayAverage": 3.869875, "currency": "USD", "enterpriseValue": 553381504, "floatShares": 86345114, "sharesOutstanding": 114856000, "sharesShort": 18945391, "sharesShortPriorMonth": 15490131, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.1649, "heldPercentInsiders": 0.20257, "heldPercentInstitutions": 0.64097, "shortRatio": 2.6, "shortPercentOfFloat": 0.24299999, "impliedSharesOutstanding": 114856000, "bookValue": 1.763, "priceToBook": 3.3011913, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -97668000, "trailingEps": -0.93, "forwardEps": -0.71, "enterpriseToRevenue": 131.538, "enterpriseToEbitda": -6.168, "52WeekChange": 0.03950107, "SandP52WeekChange": 0.22903383, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "ABSI", "underlyingSymbol": "ABSI", "shortName": "Absci Corporation", "longName": "Absci Corporation", "firstTradeDateEpochUtc": 1626960600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "cfcaddfc-dbcf-384a-9b76-cf40fa9f292c", "messageBoardId": "finmb_266013918", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.82, "targetHighPrice": 13.0, "targetLowPrice": 5.0, "targetMeanPrice": 8.625, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 127068000, "totalCashPerShare": 1.106, "ebitda": -89714000, "totalDebt": 11989000, "quickRatio": 4.817, "currentRatio": 5.626, "totalRevenue": 4207000, "debtToEquity": 5.955, "revenuePerShare": 0.04, "returnOnAssets": -0.27396, "returnOnEquity": -0.4911, "grossProfits": -45523000, "freeCashflow": -36257124, "operatingCashflow": -70360000, "revenueGrowth": 1.286, "operatingMargins": -16.98707, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]